Fosfomycin tromethamine and Depression - a phase IV clinical study of FDA data

Summary:

Depression is reported as a side effect among people who take Fosfomycin tromethamine (fosfomycin tromethamine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Prednisone, and have Headache.

The phase IV clinical study analyzes which people have Depression when taking Fosfomycin tromethamine. It is created by eHealthMe based on reports of 701 people who have side effects when taking Fosfomycin tromethamine from the FDA, and is updated regularly.

What is Fosfomycin tromethamine?

Fosfomycin tromethamine has active ingredients of fosfomycin tromethamine. eHealthMe is studying from 703 Fosfomycin tromethamine users. Check the latest studies of Fosfomycin tromethamine.

What is Depression?

Depression is found to be associated with 3,167 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.

On Jul, 11, 2026

701 people reported to have side effects when taking Fosfomycin tromethamine.
Among them, 14 people (2.0%) have Depression.

Could Fosfomycin tromethamine cause Depression?

Among these 14 people:

How long have people been on Fosfomycin tromethamine when they have Depression? *

What is the gender of people who have Depression when taking Fosfomycin tromethamine? *

female: 100 %
male: 0.0 %

What is the age of people who have Depression when taking Fosfomycin tromethamine? *

What are other drugs people take besides Fosfomycin tromethamine? *

Synthroid: 6 people, 42.86%
Sandostatin: 6 people, 42.86%
Ciprofloxacin Hydrochloride: 6 people, 42.86%
Prednisone: 6 people, 42.86%
Valsartan: 4 people, 28.57%
Cefuroxime Axetil: 4 people, 28.57%
Levothyroxine Sodium: 4 people, 28.57%
Diclofenac Sodium: 4 people, 28.57%
Metoprolol Tartrate: 4 people, 28.57%
Minocycline Hydrochloride: 4 people, 28.57%

What are other side effects people have besides Depression? *

Fatigue (feeling of tiredness): 13 people, 92.86%
Nausea (feeling of having an urge to vomit): 11 people, 78.57%
Dizziness: 11 people, 78.57%
Stress And Anxiety: 10 people, 71.43%
High Blood Pressure: 10 people, 71.43%
Urinary Tract Infection: 9 people, 64.29%
Headache (pain in head): 9 people, 64.29%
Joint Pain: 9 people, 64.29%
Hyperhidrosis (abnormally increased sweating): 7 people, 50.00%
Weakness: 7 people, 50.00%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 6 people, 42.86%
Thyroid Diseases: 6 people, 42.86%
Headache (pain in head): 6 people, 42.86%
High Blood Pressure: 4 people, 28.57%
Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 3 people, 21.43%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 21.43%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 21.43%
Cough: 3 people, 21.43%
Dyspnea (difficult or laboured breathing): 3 people, 21.43%
High Blood Cholesterol: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Fosfomycin tromethamine and have Depression?

- Check whether Depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fosfomycin tromethamine:

Fosfomycin tromethamine (703 reports)

Depression treatments and more:

Depression (652,144 reports)

Browse all side effects of Fosfomycin tromethamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depression:

Depression (3,167 drugs)

Browse all the conditions that are associated with Depression:

Depression (4,125 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fosfomycin tromethamine (the active ingredients of Fosfomycin tromethamine) and Fosfomycin tromethamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.